SEQUENOM, Inc. is a genetics company organized into two distinct business units: SEQUENOM Genetic Systems and SEQUENOM Pharmaceuticals. The Company has created a deoxyribonucleic (DNA) analysis technology and a platform that measures genetic variation. Both business units capitalize on this platform together with Sequenom's detailed knowledge of specific genetic variations in humans. SEQUENOM Genetic Systems is dedicated to the sales and support of the Company's platform, called the MassARRAY system and to the continued expansion of DNA analysis applications for use with the Company's MassARRAY system. SEQUENOM Pharmaceuticals uses MassARRAY technology and its collections of DNA samples from diseased and healthy individuals to conduct large-scale human genetics studies to systematically identify disease-related genes that affect the health of significant portions of the population.